(Q34531054)

2 August 2017

1 reference

title

Radiolabelled peptides for tumour therapy: current status and future directions. Plenary lecture at the EANM 2002. (English)

1 reference

2 August 2017

Marion de Jong

1

1 reference

2 August 2017

Dik Kwekkeboom

series ordinal

2

1 reference

2 August 2017

Roelf Valkema

series ordinal

3

1 reference

2 August 2017

Eric P Krenning

series ordinal

4

1 reference

2 August 2017

publication date

5 February 2003

1 reference

2 August 2017

number of pages

7

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

2 August 2017

volume

30

1 reference

2 August 2017

issue

3

1 reference

2 August 2017

page(s)

463-469

1 reference

Gastrin-releasing peptide receptors in non-neoplastic and neoplastic human breast

2 August 2017

cites work

1 reference

12 December 2020

Tumor response after [(90)Y-DOTA(0),Tyr(3)]octreotide radionuclide therapy in a transplantable rat tumor model is dependent on tumor size.

1 reference

12 December 2020

Tumor response and clinical benefit in neuroendocrine tumors after 7.4 GBq (90)Y-DOTATOC.

1 reference

12 December 2020

Peptide receptor imaging and therapy

1 reference

12 December 2020

End-stage renal disease after treatment with 90Y-DOTATOC.

1 reference

12 December 2020

Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients

1 reference

12 December 2020

Somatostatin receptor-targeted radionuclide therapy of tumors: preclinical and clinical findings

1 reference

12 December 2020

The clinical value of [90Y-DOTA]-D-Phe1-Tyr3-octreotide (90Y-DOTATOC) in the treatment of neuroendocrine tumours: a clinical phase II study

1 reference

12 December 2020

Pre-clinical comparison of [DTPA0] octreotide, [DTPA0,Tyr3] octreotide and [DOTA0,Tyr3] octreotide as carriers for somatostatin receptor-targeted scintigraphy and radionuclide therapy

1 reference

12 December 2020

Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide

1 reference

12 December 2020

Imaging tumors with peptide-based radioligands.

1 reference

12 December 2020

Role of nuclear medicine in the evaluation of the solitary pulmonary nodule

1 reference

12 December 2020

Co-expressed peptide receptors in breast cancer as a molecular basis for in vivo multireceptor tumour targeting

1 reference

12 December 2020

Y(1)-mediated effect of neuropeptide Y in cancer: breast carcinomas as targets

1 reference

12 December 2020

Preclinical and initial clinical evaluation of 111In-labeled nonsulfated CCK8 analog: a peptide for CCK-B receptor-targeted scintigraphy and radionuclide therapy.

1 reference

12 December 2020

Cholecystokinin-B/Gastrin receptor-targeting peptides for staging and therapy of medullary thyroid cancer and other cholecystokinin-B receptor-expressing malignancies

1 reference

12 December 2020

OctreoTher: ongoing early clinical development of a somatostatin-receptor-targeted radionuclide antineoplastic therapy

1 reference

12 December 2020

[177Lu-DOTAOTyr3]octreotate: comparison with [111In-DTPAo]octreotide in patients

1 reference

12 December 2020

Experience with indium-111 and yttrium-90-labeled somatostatin analogs

1 reference

12 December 2020

Somatostatin receptors in human cancer: incidence, characteristics, functional correlates and clinical implications

1 reference

12 December 2020

Localization of cholecystokinin A and cholecystokinin B-gastrin receptors in the human stomach

1 reference

12 December 2020

Comparison of (111)In-labeled somatostatin analogues for tumor scintigraphy and radionuclide therapy

1 reference

12 December 2020

Phase I study of peptide receptor radionuclide therapy with [In-DTPA]octreotide: the Rotterdam experience

1 reference

12 December 2020

Indium-111-pentetreotide prolongs survival in gastroenteropancreatic malignancies

1 reference

12 December 2020

Somatostatin-receptor scintigraphy in gastroenteropancreatic tumors. An overview of European results

1 reference

12 December 2020

Between the Scylla and Charybdis of peptide radionuclide therapy: hitting the tumor and saving the kidney

1 reference

12 December 2020

Treatment of patients with gastro-entero-pancreatic (GEP) tumours with the novel radiolabelled somatostatin analogue [177Lu-DOTA(0),Tyr3]octreotate

1 reference

12 December 2020

Cholecystokinin(CCK)-A and CCK-B/gastrin receptors in human tumors

1 reference

12 December 2020

Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin

1 reference

12 December 2020

Cholecystokinin receptor imaging using an octapeptide DTPA-CCK analogue in patients with medullary thyroid carcinoma

1 reference

12 December 2020

"MAURITIUS": tumour dose in patients with advanced carcinoma.

1 reference

12 December 2020

Radiolabeled peptides in the diagnosis and therapy of oncological diseases

1 reference

12 December 2020

123I-vasoactive intestinal peptide (VIP) receptor scanning: Update of imaging results in patients with adenocarcinomas and endocrine tumors of the gastrointestinal tract

1 reference

12 December 2020

Comparative somatostatin receptor scintigraphy using in-111-DOTA-lanreotide and in-111-DOTA-Tyr3-octreotide versus F-18-FDG-PET for evaluation of somatostatin receptor-mediated radionuclide therapy

1 reference

12 December 2020

[177Lu-DOTA(0),Tyr3] octreotate for somatostatin receptor-targeted radionuclide therapy

1 reference

12 December 2020

Breast cancer takes up 99mTc bombesin. A preliminary report

1 reference

12 December 2020

Vasoactive intestinal peptide receptor scintigraphy

1 reference

12 December 2020

Relationships between tumor size and curability for uniformly targeted therapy with beta-emitting radionuclides

1 reference

12 December 2020

Localisation of endocrine-related tumours with radioiodinated analogue of somatostatin

1 reference

12 December 2020

Local injection of the 90Y-labelled peptidic vector DOTATOC to control gliomas of WHO grades II and III: an extended pilot study

1 reference

12 December 2020

Targeting of cholecystokinin-B/gastrin receptors in vivo: preclinical and initial clinical evaluation of the diagnostic and therapeutic potential of radiolabelled gastrin

1 reference

12 December 2020

Indium-111-DOTA-lanreotide: biodistribution, safety and radiation absorbed dose in tumor patients

1 reference

12 December 2020

Cholecystokinin-B/gastrin receptor binding peptides: preclinical development and evaluation of their diagnostic and therapeutic potential

1 reference

12 December 2020

Visualization of the thymus by substance P receptor scintigraphy in man

1 reference

12 December 2020

Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use

1 reference

12 December 2020

Bombesin receptor subtypes in human cancers: detection with the universal radioligand (125)I-[D-TYR(6), beta-ALA(11), PHE(13), NLE(14)] bombesin(6-14)

1 reference

12 December 2020

Comparison of 111In-DOTA-Tyr3-octreotide and 111In-DTPA-octreotide in the same patients: biodistribution, kinetics, organ and tumor uptake

1 reference

12 December 2020

Somatostatin receptors in malignant tissues

1 reference

12 December 2020

Receptor-mediated radiotherapy with Y-DOTA-DPhe-Tyr-octreotide: the experience of the European Institute of Oncology Group

1 reference

12 December 2020

In- and Y-DOTA-lanreotide: results and implications of the MAURITIUS trial

1 reference

12 December 2020

In vitro and in vivo detection of somatostatin receptors in human malignant tissues

1 reference

12 December 2020

Gastrin-releasing peptide receptors in the human prostate: relation to neoplastic transformation.

1 reference

12 December 2020

Receptor-mediated radiotherapy with 90Y-DOTA-D-Phe1-Tyr3-octreotide

1 reference

12 December 2020

In situ radiotherapy with 111In-pentetreotide. State of the art and perspectives.

1 reference

12 December 2020

A multicenter trial with a somatostatin analog (99m)Tc depreotide in the evaluation of solitary pulmonary nodules

1 reference

12 December 2020

Nephrotoxicity versus anti-tumour efficacy in radiopeptide therapy: facts and myths about the Scylla and Charybdis

1 reference

12 December 2020

Safe and effective inhibition of renal uptake of radiolabelled octreotide by a combination of lysine and arginine

1 reference

12 December 2020

Phase I trial of technetium [Leu13] bombesin as cancer seeking agent: possible scintigraphic guide for surgery?

1 reference

12 December 2020

10.1007/S00259-002-1107-8

Identifiers

DOI

1 reference

2 August 2017

1 reference